Across industries, the pace to introduce new products is increasing. This puts pressure on companies to shorten the design and development cycles. Medical devices are no exception in this respect.
Recent Posts
With their next-generation innovation, Synoste aims to renew surgical treatment related to bone deformities. Innokas Medical is involved in this mission by being one of Synoste's co-creation partners...
Healthcare technology is one of the largest high-tech export segments of Finnish industry, and it continues to grow strongly year after year. In addition to growth, the industry is evolving with...
WellO2, innovation developed by the Finnish company WellO2 Oy (formerly known as Hapella Oy), is a breathing exercise device that strengthens and cleanses the lungs. The mission of the company is to...
The collaborative consortium has received a significant funding from Business Finland. This two-year Stroke-DATA -project, which is one part of Business Finland’s Smart Life program, is carried out...
Norwegian healthtech innovator Augere Medical AS has selected Innokas Medical as their co-creation partner to offer quality and regulatory as well as design and development support to bring their...
When creating a new medical device to the market, there’s much more that goes into designing, developing and introducing it to the market. To be able to enter the certain markets, the development and...
The importance of SW is growing – also in medical devices and as medical devices. This blog text deals with the change of SW’s role, the tightening regulations landscape as well as how to be agile...
